Product Information
COTEMPLA XR-ODT 17.3 MG TABLET is a brand product labeled by Neos Therapeutics Brands, LLC, priced at $18.0380 per EA under NDC 70165020030. Its NADAC has been published 441 times since Jan 17, 2018.
The High Outlier badge above means this manufacturer's average price in the Methylphenidate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
17.3 mg/1
Manufacturer
Neos Therapeutics Brands, LLCNDC
70165020030
Classification
Brand
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Last Updated
4/1/2026
Active Ingredients
METHYLPHENIDATEApproval Type
New Drug (NDA)
FDA Application
NDA205489On Market Since
6/20/2017
Pharmacological Classes
Price Statistics
The NADAC for COTEMPLA XR-ODT 17.3 MG TABLET has been published 441 times since Jan 17, 2018, and over the history we have for it it has risen 76.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $18.0380 per EA |
|---|---|
| All-time high | $18.0380 (Jun 24, 2026) |
| All-time low | $10.2304 (Jan 17, 2018) |
| 52-week high | $18.0380 |
| 52-week low | $17.0932 |
| Median price | $14.3192 |
| Average price | $14.3387 |
| Largest weekly change | +13.2% (Jan 1, 2020) |
| Weeks tracked | 441 |
| Tracking since | Jan 17, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Methylphenidate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of COTEMPLA XR-ODT 17.3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for COTEMPLA XR-ODT 17.3 MG TABLET, manufactured by Neos Therapeutics Brands, LLC, is $18.0380 per EA (NDC 70165020030), effective Jun 24, 2026.
How has the price of COTEMPLA XR-ODT 17.3 MG TABLET changed over time?
Over the history we have for it, the NADAC for COTEMPLA XR-ODT 17.3 MG TABLET has risen 76.3%. It has been tracked across 441 weekly CMS publications since Jan 17, 2018.
What are the highest and lowest recorded NADAC prices for COTEMPLA XR-ODT 17.3 MG TABLET?
Since Jan 17, 2018, the NADAC for COTEMPLA XR-ODT 17.3 MG TABLET has ranged from a low of $10.2304 (Jan 17, 2018) to a high of $18.0380 (Jun 24, 2026), with a median of $14.3192 per EA.
Are there cheaper alternatives to COTEMPLA XR-ODT 17.3 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of COTEMPLA XR-ODT 17.3 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures COTEMPLA XR-ODT 17.3 MG TABLET?
COTEMPLA XR-ODT 17.3 MG TABLET (NDC 70165020030) is labeled by Neos Therapeutics Brands, LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification